Proposal to list medical devices supplied by Medtronic New Zealand Limited
What we’re proposing
Pharmac is seeking feedback on a proposal to list patient assessment, monitoring and treatment medical devices supplied by Medtronic New Zealand Limited (“Medtronic”) in Part III of Section H of the Pharmaceutical Schedule from 1 December 2024 through a non-exclusive provisional agreement.
Consultation closes at 4pm, Friday 1 November 2024 and feedback can be emailed to alyssa.currie@pharmac.govt.nz.
What would the effect be?
From 1 December 2024 patient assessment, monitoring and treatment medical devices supplied by Medtronic would be listed in the Pharmaceutical Schedule under a national agreement for all Health New Zealand | Te Whatu Ora (“Health NZ”) hospitals to purchase under, subject to consultation and approval by Pharmac’s Board or delegate.
The agreement would not be for sole supply and Health NZ hospitals can continue to purchase other suppliers’ brands of patient assessment, monitoring and treatment medical devices.
The agreement would supersede any existing Health NZ contracts with Medtronic for the medical devices included in the agreement. Any medical device listed in the agreement, and purchased by a Health NZ hospital, would be in accordance with the terms and conditions, including price, stated in the agreement effective from the date of listing in the Pharmaceutical Schedule.
Pricing for medical devices in the agreement, subject to any prior termination of the agreement, would not be increased without prior consultation and approval by Pharmac.
Who we think will be interested
- Health NZ staff including but not limited to the following areas:
- Audiologists
- Clinical engineers and maintenance services
- Clinical Product Coordinators
- Dermatologists
- ENT clinicians
- Gastroenterologists
- Neurosciences
- Nurses
- Ophthalmologists
- Patient Monitoring
- Perioperative staff
- Procurement and supply chain personnel
- Psychologists
- Somnology
- Urologists
- Vascular medicine clinicians
- Wards and outpatient clinics
- Suppliers and wholesalers
About these products
Patient assessment, monitoring and treatment devices include equipment and consumable medical devices that are used in a variety of clinical settings to assess, monitor and treat patients. Clinical areas of use include Audiology, Ear, Nose and Throat (ENT), Dermatology, Gastroenterology, Neurosciences and Psychology, Ophthalmology, Somnology, Urology, Vascular Medicine, Wards and Outpatient Clinics.
Why we’re proposing this
Pharmac issued a Request for Proposal (“RFP”) for:
The RFP was for non-exclusive national agreements for listing on the Pharmaceutical Schedule.
Pharmac has been working with suppliers who responded to the RFP, and were successful in being progressed to contract negotiation, to seek provisional agreements. This proposal is the latest to arise from this process.
Details about our proposal
Pharmac has entered into a provisional agreement with Medtronic for the supply of patient assessment, monitoring and treatment devices. The proposal would result in listing 262 medical devices covering the following brands:
- INVOS
- ManoScan
- Medtronic
- Merocel
- Merogel
- Nellcor
- Oridion
- South Medic
Further information, including pricing and contractual details, has been provided to Health NZ procurement personnel. Clinicians interested in further detail on what the proposal means for their hospital should engage with the procurement team.
To provide feedback
Send us an email: alyssa.currie@pharmac.govt.nz by 4pm, Friday 1 November 2024.
All feedback received before the closing date will be considered by Pharmac’s Board (or its delegate) prior to making a decision on this proposal.
Your feedback may be shared
Feedback we receive is subject to the Official Information Act 1982 (OIA). Please be aware that we may need to share your feedback, including your identity, in response to an OIA request. This applies to anyone providing feedback, whether they are providing feedback themselves or for an organisation, in a personal or professional capacity.
We can only keep feedback confidential as allowed under the OIA and other related laws. If you want any part of your feedback treated as confidential, you need to tell us. Please let us know if you want to keep part of your feedback confidential, and why. Is it commercially sensitive, confidential or proprietary, or personal information? Clearly state this and tell us which parts of your feedback you want to keep confidential for these reasons. We will consider your request under our OIA requirements.